Relevant bibliographies by topics / Movement and psychiatric disorders

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Movement and psychiatric disorders'

Author: Grafiati
Published: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Movement and psychiatric disorders.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Movement and psychiatric disorders"

1

Perju-Dumbrava, Laura, and Peter Kempster. "Movement disorders in psychiatric patients." BMJ Neurology Open 2, no. 2 (December 2020): e000057. http://dx.doi.org/10.1136/bmjno-2020-000057.

Full text
Abstract:
The observability of movement gives it advantages when trying to draw connections between brain and mind. Disturbed motor function pervades schizophrenia, though it is difficult now to subtract the effects of antipsychotic treatment. There is evidence from patients never exposed to these drugs that dyskinesia and even parkinsonism are to some degree innate to schizophrenia. Tardive dyskinesia and drug-induced parkinsonism are the most common movement disorders encountered in psychiatric practice. While D2 dopamine receptor blockade is a causative factor, both conditions defy straightforward neurochemical explanation. Balanced against the need to manage schizophrenic symptoms, neither prevention nor treatment is easy. Of all disorders classified as psychiatric, catatonia sits closest to organic neurology on the neuropsychiatric spectrum. Not only does it occur in the setting of unequivocally organic cerebral disease, but the alterations of consciousness it produces have ‘organic’ qualities even when the cause is psychiatric. No longer considered a subtype of schizophrenia, catatonia is defined by syndromic features based on motor phenomenology. Both severe depression and obsessive-compulsive disorder may be associated with ‘soft’ extrapyramidal signs that resemble parkinsonian bradykinesia. As functional neuroimaging studies suggest, movement and psychiatric disorders involve the same network connections between the basal ganglia and the cerebral cortex.
APA, Harvard, Vancouver, ISO, and other styles
2

Miguel-Puga, Adán, Gabriel Villafuerte, and Oscar Arias-Carrión. "Psychiatric comorbidities in movement disorders." International Review of Psychiatry 29, no. 5 (July 6, 2017): 516–26. http://dx.doi.org/10.1080/09540261.2017.1322043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Monahan, R., A. Blonk, H. Middelkoop, M. Kloppenburg, T. Huizinga, N. Van der Wee, and G. M. Steup-Beekman. "POS0708 PSYCHIATRIC DISORDERS IN PATIENTS WITH DIFFERENT PHENOTYPES OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS (NPSLE)." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 603.2–604. http://dx.doi.org/10.1136/annrheumdis-2021-eular.423.

Full text
Abstract:
Background:Patients with systemic lupus erythematosus (SLE) may present with psychiatric disorders. These are important to recognize, as they influence quality of life and treatment outcomes and strategies.Objectives:We aimed to study the frequency of psychiatric morbidity as classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) in patients with SLE and neuropsychiatric symptoms of different origins.Methods:In the neuropsychiatric SLE (NPSLE) clinic of the Leiden University Medical Center, patients undergo a standardized multidisciplinary assessment by a neurologist, neuropsychologist, vascular internal medicine, rheumatologist, physician assistant and psychiatrist. After two weeks, a multidisciplinary consensus meeting takes place, in which the symptoms are attributed to SLE requiring treatment (major NPSLE) or to minor involvement of SLE or other causes (minor/non-NPSLE). Consecutive patients visiting the NPSLE clinic between 2007-2019 were included. Data of psychiatric evaluation and current medication use were extracted from medical records. The presence of cognitive dysfunction was established during formal neuropsychological assessment.Results:371 consecutive SLE patients were included, of which 110 patients had major NPSLE (30%). Mean age was 44 ± 14 years and 87% was female.The most frequently diagnosed psychiatric disorders in the total group were cognitive dysfunction (42%) and depression (23%), as shown in Table 1. Furthermore, anxiety was present in 5% and psychotic disorders in 4% of patients. In patients with minor/non-NPSLE, especially depression (26% vs 15%) and anxiety (6% vs 2%) were more common than in major NPSLE. Cognitive dysfunction (54% vs 36%) and psychotic disorders (6% vs 4%) were more common in patients with major NPSLE than minor/non-NPSLE.Psychiatric medication was used in 33% of patients, of which antidepressants and benzodiazepines the most frequently (both: 18% in both subgroups). Antipsychotics were more often used in patients with NPSLE (10% vs 7%) and benzodiazepines more often in minor/non-NPSLE (20% vs 14%).In addition, 17 patients (5%) had a history of suicide attempt, which was more common in patients with minor/non-NPSLE than major NPSLE (6% vs 2%).Conclusion:Psychiatric morbidity, especially cognitive dysfunction and depression, are common in patients with lupus and differ between underlying cause of the neuropsychiatric symptoms (minor/non-NPSLE vs major NPSLE).Table 1.Presence of psychiatric diagnoses in patients with SLE and neuropsychiatric symptomsAll patients(n = 371)Minor/non-NPSLE(n = 261)Major NPSLE(n = 110)DSM V diagnosis, n (%)Neurodevelopmental disorder5 (1)2 (1)3 (2)Schizophrenia Spectrum and Other Psychotic Disorders16 (4)10 (4)6 (6)Bipolar and related disorders7 (2)5 (2)2 (2)Depressive disorders84 (23)68 (26)16 (15)Anxiety disorders17 (5)15 (6)2 (2)Obsessive-Compulsive and Related Disorders1 (0)1 (0)0 (0)Trauma- and Stressor-Related Disorders16 (4)12 (5)4 (3)Dissociative Disorders2 (1)2 (1)0 (0)Somatic Symptom and Related Disorders1 (0)1 (0)0 (0)Feeding and Eating Disorders0 (0)1 (0)0 (0)Elimination Disorders0 (0)0 (0)0 (0)Sleep-wake disorders2 (1)2 (1)0 (0)Sexual dysfunctions0 (0)0 (0)0 (0)Gender dysphoria0 (0)0 (0)0 (0)Disruptive, Impulse-Control, and Conduct Disorder0 (0)0 (0)0 (0)Substance-related and addictive disorders9 (2)8 (3)1 (1)Cognitive dysfunction154 (42)95 (36)59 (54)Personality disorders10 (3)9 (3)1 (1)Paraphilic disorders0 (0)0 (0)0 (0)Other mental disorders12 (3)7 (3)5 (5)Medication-Induced Movement Disorders and Other Adverse Effects of Medication0 (0)0 (0)0 (0)Unknown3 (1)3 (1)0 (0)NPSLE = neuropsychiatric systemic lupus erythematosus.Disclosure of Interests:None declared
APA, Harvard, Vancouver, ISO, and other styles
4

Wetter, T. C. "Insomnia and nocturnal movement disorders." European Psychiatry 26, S2 (March 2011): 2175. http://dx.doi.org/10.1016/s0924-9338(11)73878-0.

Full text
Abstract:
Little is known about the prevalence of nocturnal movement disorders in patients with insomnia or psychiatric disorders. However, it is well established that sleep-related motor disorders (movement disorders, parasomnias) are associated with psychopharmacological treatment. In a recent prospective study it has been shown that second-generation antidepressants may induce or worsen symptoms of restless legs syndrome (RLS) which is often associated with insomnia. While pure SSRIs and SNRIs carried an average risk of about 5% for triggering RLS, reboxetine did not seem to induce this syndrome. By contrast, mirtazapine caused or worsened RLS in almost 30% of the patients surveyed (Rottach et al., 2009). Other studies using polysomnography have reported an increased risk of periodic leg movement disorder with antidepressant treatment. It was reported that SSRIs and venlafaxine, but not bupropion, increased the risk of periodic leg movements during sleep (PLMS), suggesting that PLM activity seen in association with antidepressant administration might be serotonergically mediated (Yang et al., 2004). Sleep-related movement disorders may also occur under treatment with first- or second-generation neuroleptics (Cohrs et al., 2008). Administration of antidepressants may also induce the occurence of rapid eye movment (REM) sleep parasomnias such as REM sleep behaviour disorder (RBD) (Thomas et al., 2007). Own preliminary data of an ongoing study revealed that sleep-disordered patients with comorbid psychiatric disorders are more likely to report a variety of nocturnal movement disorders using the Munich Parasomnia Screening Questionnaire. However, whether this result is due to the psychopharmacological medication remains to be determined.
APA, Harvard, Vancouver, ISO, and other styles
5

Robertson, M. M. "The psychiatric aspects of movement disorders." Current Opinion in Psychiatry 3, no. 1 (February 1990): 83–89. http://dx.doi.org/10.1097/00001504-199002000-00020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rigby, Heather, Angela Roberts-South, Hrishikesh Kumar, Leonardo Cortese, and Mandar Jog. "Diagnostic Challenges Revealed from a Neuropsychiatry Movement Disorders Clinic." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 39, no. 6 (November 2012): 782–88. http://dx.doi.org/10.1017/s0317167100015614.

Full text
Abstract:
Background:Abnormal movements are frequently associated with psychiatric disorders. Optimized management and diagnosis of these movements depends on correct labeling. However, there is evidence of reduced accuracy in the labeling of these movements, which could result in sub-optimal care.Objective:To determine the consensus inter-rater reliability between a movement disorders neurologist and physicians referring from the community for phenomenology and diagnoses of individuals with co-existing psychiatric conditions and movement disorders.Method:Charts of all consecutive patients seen in a combined Movement Disorders and Neuropsychiatry Clinic between 2001-2009 were reviewed retrospectively. Consensus estimates and kappa values for inter-rater reliability were determined for phenomenology and diagnostic terms for the respective referring source and movement disorders neurologist for each patient.Results:A total of 106 charts were reviewed (62 men and 44 women). Agreement for phenomenology terms ranged from 0% (psychogenic) to 73% (tremor). Only 3 terms had kappa values that met or exceeded criteria for moderate inter-rater reliability. Agreement for diagnosis terms was highest for tardive dyskinesia (83%), drug induced tremor (33%), and drug induced parkinsonism (20%). In 18 of the 22 charts (82%), a diagnosis was made of drug induced movement disorder (DIMD) by the referring physician. In contrast, a diagnosis of DIMD was made in only 54 of 106 charts (51%) after the patients were assessed in the clinic.Conclusions:A movement disorders specialist frequently disagreed with referring physicians' identification of patient phenomenology and diagnosis. This suggests that clinicians would benefit from educational resources to assist in characterizing abnormal movements.
APA, Harvard, Vancouver, ISO, and other styles
7

Biolsi, Brigitte, Laura Cif, Hassan El Fertit, Santiago Gil Robles, and Philippe Coubes. "Long-term follow-up of Huntington disease treated by bilateral deep brain stimulation of the internal globus pallidus." Journal of Neurosurgery 109, no. 1 (July 2008): 130–32. http://dx.doi.org/10.3171/jns/2008/109/7/0130.

Full text
Abstract:
Deep brain stimulation is now accepted as a safe and efficient treatment for movement disorders including selected types of dystonia and dyskinesia. Very little, however, is known about its effect on other movement disorders, particularly for “choreic” movements. Huntington disease is a fatal autosomal-dominant neurodegenerative disorder characterized by movement disorders, progressive cognitive impairment, and psychiatric symptoms. Bilateral chronic stimulation of the internal globus pallidus was performed to control choreic movements in a 60-year-old man with a 10-year history of Huntington disease. Chronic deep brain stimulation resulted in remarkable improvement of choreic movements. Postoperative improvement was sustained after 4 years of follow-up with a marked improvement in daily quality of life.
APA, Harvard, Vancouver, ISO, and other styles
8

Walsh, Kelda Harris, Katherine Soe, and Shivali Sarawgi. "Psychiatric Treatment and Management of Psychiatric Comorbidities of Movement Disorders." Seminars in Pediatric Neurology 25 (April 2018): 123–35. http://dx.doi.org/10.1016/j.spen.2017.12.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Menza, Matthew A., Nancy Grossman, Margaret Van Horn, Ronald Cody, and Nancy Forman. "Smoking and movement disorders in psychiatric patients." Biological Psychiatry 30, no. 2 (July 1991): 109–15. http://dx.doi.org/10.1016/0006-3223(91)90163-g.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mandolesi, L., G. Piraccini, F. Ambrosini, F. L. Vetere, R. P. Sant’Angelo, R. Raggini, and M. Benassi. "Smooth pursuit eye movements in psychiatric inpatients." European Psychiatry 41, S1 (April 2017): S764—S765. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1438.

Full text
Abstract:
IntroductionEye movements are used in several studies as a biomarker in order to evaluate cortical alterations in psychiatric disorders. Pursuit eye movements’ deficits were found both in schizophrenia and in affective disorder patients. Nevertheless, these findings are still controversial.ObjectivesSet up a system to record and evaluate the eye movements in psychiatric patients.AimsTo verify the applicability of a smooth pursuit task in a sample of psychiatric inpatients and to prove its efficiency in discriminating patient and control group performance.MethodsA sample of psychiatric inpatients was tested at psychiatric service of diagnosis and care of AUSL Romagna-Cesena. Eye movement measures were collected at a sampling rate of 60 Hz using the eye tribe tracker, a bar plugged into a PC, placed below the screen and containing both webcam and infrared illumination. Subjects underwent to a smooth pursuit eye movement task. They had to visually follow a white dot target moving horizontally on a black background with a sinusoidal velocity. At the end of the task, a chart of the eye movements done is shown on the screen. Data are off-line analyzed to calculate several eye movement parameters: gain, eye movement delay with respect to the movement of the target, maximum speed and number of saccades exhibited during pursuit.ResultsPatients compared to controls showed higher delay and lower gain values.ConclusionsFindings confirm the adequacy of this method in order to detect eye movement differences between psychiatric patients and controls in a smooth pursuit task.Disclosure of interestThe authors have not supplied their declaration of competing interest.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Movement and psychiatric disorders"

1

Lorentzos, Michelle Sarah. "The Psychiatry of Paediatric Movement Disorders." Thesis, The University of Sydney, 2019. http://hdl.handle.net/2123/20602.

Full text
Abstract:
I compared the rate of psychiatric comorbidity in children with Non-tic movement disorders to children with tics and TS. In addition, this PhD explores whether children with Non-tic movement disorders have elevated rates of psychiatry compared to other hospital populations, including Emergency patients and other Neurology patients, as well as a healthy community control group. My hypothesis was that children with Non-tic movement disorders would have rates of psychiatric comorbidities that are similar to children with tics and TS.To examine this hypothesis, I recruited children between the ages of 5 and 16 years from Neurology clinics at The Children’s Hospital at Westmead, Australia, and Great Ormond Street Hospital, United Kingdom, for the following two movement disorder groups: tic movement disorder cohort (consisting of patients with tics and Tourette Syndrome, n=158) and Non-tic movement disorder cohort, (consisting of patients with all other movement disorders, n=102). An additional 137 patients were recruited for two clinical control groups: the Emergency department control cohort (n=100) and the Neurology control cohort including children with peripheral neuropathy or epilepsy (n=37). In addition, data from 10,438 British children were included as a retrospective community control. All patients were screened for psychiatric comorbidities using the Development and Wellbeing Assessment Tool (DAWBA). My primary outcome was that the difference in the rate of psychiatric comorbidity in the Non-tic cohort (39.2%) and the Tic cohort (41.8%) was not statically significant. Importantly, the rate of psychiatric comorbidity in the Non-tic cohort was more than four times the rate of psychiatric diagnosis observed in the large retrospective community cohort (9.5%) (p<0.00001). This is the largest study to date exploring psychiatry in children with paediatric dystonia (n=66) and psychiatric comorbidities occurred in 33.3% of these patients. In conclusion, this study recognises that children with non-tic movement disorders are just as vulnerable to psychiatric comorbidities as children with tics and TS. This new evidence may encourage clinicians to consider screening for psychiatric comorbidities in their movement disorder patients, therefore allowing for earlier diagnosis and treatment.
APA, Harvard, Vancouver, ISO, and other styles
2

Von, Tersch Elise. "Modified Eye Movement Desensitization Therapy Protocol Treating Substance Abuse Disorders." ScholarWorks, 2019. https://scholarworks.waldenu.edu/dissertations/7346.

Full text
Abstract:
Quality substance abuse treatment is needed to help fight the battle against drug addiction. This qualitative study was designed to explore some of the approaches to eye movement desensitization (EMDR) therapy that therapists trained in Parnell's adapted EMDR model use in conjunction with treatment for addictions. The purpose of this narrative inquiry was to investigate the experience of therapists who incorporate substance abuse treatment with Parnell's adapted EMDR model when treating trauma and substance use disorders. The population studied comprised licensed mental health therapists who had completed Parnell's EMDR training and implemented Parnell's modified EMDR protocol in their professional practice. The data from 9 participant interviews were coded and NVIVO data analysis software was used to identify key concepts and themes including deviations from Parnell's modified protocol, incorporating addiction treatment within the modified protocol, and the importance of the resourcing phase in the modified protocol. The study findings provided a deeper understanding of the types of addiction therapies that therapists are using in conjunction with Parnell's EMDR model. The results also showed that that participants perceived Parnell's EMDR model, combined with addiction therapeutic techniques and approaches, as beneficial in treating those with trauma and substance use disorders. By integrating addiction therapies with Parnell's EMDR protocol, EMDR certified trainers may better educate EMDR trainees about useful strategies for treating dual diagnosed clients. The strategies may shorten the client's time in treatment and provide a strong foundation for therapists as they conduct therapy for dual diagnosed people.
APA, Harvard, Vancouver, ISO, and other styles
3

Pilli, Deepti. "The Autoimmune T cell Response Against the Dopamine-2 Receptor in Movement and Psychiatric Disorders." Thesis, The University of Sydney, 2020. https://hdl.handle.net/2123/22465.

Full text
Abstract:
Autoimmunity and immune dysregulation are associated with a subset of movement and psychiatric disorders. This paradigm is largely supported by the discovery of autoantibodies against neuronal antigens, like the dopamine-2 receptor (D2R). T cells are a prominent cell subset in the immune system, however, their role in these diseases is unknown. Herein, we identified and characterised D2R-specific T cells in movement and psychiatric disorders in children and adults. In children with suspected autoimmune or neurodevelopmental movement and psychiatric disorders (n=24), activated D2R-specific T cells were detected in 8/24 (33%) patients when their peripheral blood was stimulated with a library of D2R peptides and assessed for CD25+CD134+CD4+ T cells via flow cytometry. The D2R-specific T cells recognised three immunodominant regions: aa121-131, aa171-181, and aa396-416. These regions were predicted with computational methods to bind with high affinity to the HLA of D2R-specific T cell positive patients and were associated with elevated levels of pro-inflammatory cytokines that characterise Th1 and Th17 cells, as quantified by a cytometric bead array and an enzyme-linked immunosorbent assay. The eight D2R-specific T cell-positive patients were seronegative for D2R antibodies, as evaluated with the flow cytometry live cell-based assay. These findings on autoreactive T cells in children formed the basis for investigating D2R-specific T cells in adults with isolated dystonia, a movement disorder that is often idiopathic and has been associated with impaired dopamine signalling. In adults with dystonia (n=20), activated D2R-specific T cells were detected in 6/20 (30%) patients via flow cytometry after stimulation with seven immunogenic regions of D2R. A subset of the D2R-specific T cell-positive patients had activated CD39+ Treg cells (2/6) and 1/6 D2R-specific T cell-positive patient concomitantly harboured activated CXCR5+ Tfh cells and D2R antibodies. In summary, this thesis offers new insights into autoreactive T cells against D2R in the movement and psychiatric disorders. Our observations encourage studies to further understand explore T cell dysregulation to better identify novel subsets of movement and psychiatric disorders and have clinical implications in improving diagnosis and treatment.
APA, Harvard, Vancouver, ISO, and other styles
4

Sinmaz, Nese. "Analysis of the binding specificity of dopamine-2 receptor antibodies in paediatric autoimmune movement and psychiatric disorders." Thesis, The University of Sydney, 2017. http://hdl.handle.net/2123/17569.

Full text
Abstract:
Over the last decade, multiple autoantibodies targeting brain proteins and receptors have been identified in adults and children. Autoantibody exposure in the brain can lead to transient or permanent behavioural or cognitive abnormalities. Current treatment options for autoimmune brain-reactive autoantibody-associated diseases include global immunosuppressive therapies, but these can have severe side effects, and are not always efficacious. Understanding the nature and specificity of brain autoantibodies may reveal potential therapeutic strategies alleviating or preventing the neurological pathologies and behavioural abnormalities associated with antibody-mediated brain disorders. Recently, anti-dopamine-2 receptor (D2R) antibodies have been identified in a subgroup of children with autoimmune movement and psychiatric disorders. D2R is an important brain receptor involved a variety of functions including voluntary movement, learning, memory, attention, and hormonal regulation. Currently, knowledge of the function of D2R tertiary structures, including the extracellular N-terminus, is limited, and its role in autoantibody binding is unknown. Here we report a major biological role for D2R extracellular N-terminus as a regulator of receptor surface availability, and as a major epitope targeted in brain autoimmunity. Human embryonic kidney cells were transfected with D2R mutants modified in their extracellular domains, and the level of cell surface expression and epitope specificity of 35 anti-D2R antibody-positive patient sera were analysed using a quantitative flow cytometry assay. We found that N-glycosylation at amino acids N5 and/or N17 was critical for high surface expression via interaction with the last 15 residues of extracellular D2R N-terminus. No anti-D2R antibody-positive patient sera bound to the three extracellular loops, but all patient sera (35/35) targeted the extracellular N-terminus. Overall, patient antibody binding was dependent on two main regions encompassing amino acids 20 to 29, and 23 to 37. Residues 20 to 29 contributed to the majority of binding (77 %, 27/35), among which sera from 26 % (7/27) of patients bound to amino acids R20, P21, and F22, 37 % (10/27) patient sera binding was dependent on residues at positions 26 and 29, and 30% (8/27) sera required R20, P21, F22, N23, D26, and A29. Seven patient sera bound to the region 23 to 37 independently of D26 and A29, but most sera exhibited N-glycosylation-independent epitope recognition at N23. Interestingly, no evident segregation of binding pattern according to patient clinical phenotypes was observed. Finally, we describe the optimisation of a method for single-cell isolation and RT-PCR for the generation of monoclonal antibodies. D2R N-terminus is a central epitope in autoimmune movement and psychiatric disorders, and this knowledge could help the design of novel specific immune therapies tailored to improve patient outcome.
APA, Harvard, Vancouver, ISO, and other styles
5

Carmany, Johanna. "Dance as Treatment for Orthorexia Nervosa." Scholarship @ Claremont, 2018. http://scholarship.claremont.edu/cmc_theses/1834.

Full text
Abstract:
This project presents dance as treatment for Orthorexia Nervosa, an eating disorder defined as an unhealthy obsession with healthy eating. Eating disorders disconnect body, mind, and spirit of an individual, and dance therapeutically connects these aspects. The specific effects of orthorexia on the body, mind, and spirit are analyzed; supported by evidence from research sources such as literature of books and scholarly journals, videos, an interview with board-certified dance/movement therapist Rachel Gonick-Mefferd, and a series of interviews with Dr. Thomas Doyle, in which he supplied a case study exemplifying dance as treatment for orthorexia. Conclusively, eating disorders and specifically orthorexia affect one’s entire being — physical, mental, emotional, social, spiritual health — and interfere with one’s entire life and daily functioning. Dance, as a holistic therapeutic approach, is effective in addressing and remedying every single one of these elements, healing one’s whole self. Therefore, it is suggested that dance may be an effective treatment for orthorexia.
APA, Harvard, Vancouver, ISO, and other styles
6

Soda, Takahiro. "Converging biochemical pathways in psychiatric disorders." Thesis, Massachusetts Institute of Technology, 2012. http://hdl.handle.net/1721.1/73775.

Full text
Abstract:
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Brain and Cognitive Sciences, 2012.
Cataloged from PDF version of thesis.
Includes bibliographical references.
According to the World Health Organization, neuropsychiatric diseases account for approximately one third of years lost to disability. Yet, despite this huge disease burden, there is a lack of new treatments under development: approved treatments all essentially target the same target(s), if the target itself is known. There is now considerable evidence for a common set of heritable risk for psychiatric disorders including schizophrenia, bipolar disorder, as well as autism. Many of these risk alleles affect genes implicated in neuronal development with known roles at an early stage; these genes would have an effect on the individual before the onset of overt symptoms or diagnosis. Furthermore, many of the genes identified are known to participate in established pathways that are relevant for neuronal development and function. It is important then to address the causality between these signaling pathways that are important for neurodevelopment, and the risk of developing neuropsychiatric disorder. The work presented in this thesis represents two projects that aim to work toward this goal. The first project pertains to the mechanisms of transcriptional repression by DISC1 on ATF4-mediated gene transcription. The second project presents some initial steps towards uncovering the role of BCL9 in neuronal development.
by Takahiro Soda.
Ph.D.
APA, Harvard, Vancouver, ISO, and other styles
7

Nika, O. M. "Comorbidity of migraine and psychiatric disorders." Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18745.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Osuna, Bradley J. "Self-Constitution and Mild Psychiatric Disorders." Ohio University / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ohiou1588339343277725.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Diorio, Diane Lynn. "Peripheral benzodiazepine binding sites in psychiatric disorders." Thesis, McGill University, 1989. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=55676.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dodwell, D. J. F. "Neuropsychological and psychiatric disorders following head injury." Thesis, University of Manchester, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.306085.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Movement and psychiatric disorders"

1

G, Walsh Peter, and Sturmey Peter, eds. Stereotyped movement disorders. Chichester: Wiley, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Daniel, Tarsy, ed. Deep brain stimulation in neurological and psychiatric disorders. Totowa, NJ: Humana Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

A, Wisniewski Alexander, ed. Movement disorders: A neuropsychiatric approach. New York: Guildford Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

A, Wisniewski Alexander, ed. Movement disorders: A neuropsychiatric approach. Chichester: Wiley, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Motor disorder in psychiatry: Towards a neurological psychiatry. Chichester: J. Wiley & Sons, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

New York Academy of Sciences, ed. Brain stimulation in neurology and psychiatry: Advances, opportunities, and challenges. Boston, Mass: Published by Blackwell Pub. on behalf of the New York Academy of Sciences, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sax, William, and Claudia Lang, eds. The Movement for Global Mental Health. NL Amsterdam: Amsterdam University Press, 2021. http://dx.doi.org/10.5117/9789463721622.

Full text
Abstract:
In The Movement for Global Mental Health: Critical Views from South and Southeast Asia, prominent anthropologists, public health physicians, and psychiatrists respond sympathetically but critically to the Movement for Global Mental Health (MGMH). They question some of its fundamental assumptions: the idea that "mental disorders" can clearly be identified; that they are primarily of biological origin; that the world is currently facing an "epidemic" of them; that the most appropriate treatments for them normally involve psycho-pharmaceutical drugs; and that local or indigenous therapies are of little interest or importance for treating them. The contributors argue that, on the contrary, defining "mental disorders" is difficult and culturally variable; that social and biographical factors are often important causes of them; that the "epidemic" of mental disorders may be an effect of new ways of measuring them; and that the countries of South and Southeast Asia have abundant, though non-psychiatric, resources for dealing with them. In short, they advocate a thoroughgoing mental health pluralism.
APA, Harvard, Vancouver, ISO, and other styles
8

American Psychiatric Association. Task Force on Tardive Dyskinesia. Tardive dyskinesia: A task force report of the American Psychiatric Association. Washington, DC: The Association, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Davidson, Larry. The roots of the recovery movement in psychiatry: Lessons learned. Chicester, West Sussex, UK: Wiley-Blackwell, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lee, Ellie. Abortion, motherhood, and mental health: Medicalizing reproduction in the United States and Great Britain. New York: Aldine de Gruyter, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Movement and psychiatric disorders"

1

Lam, Siu Ping, Jihui Zhang, Shirley Xin Li, and Yun Kwok Wing. "RBD, Antidepressant Medications, and Psychiatric Disorders." In Rapid-Eye-Movement Sleep Behavior Disorder, 123–34. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-90152-7_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zurowski, M., V. Voon, and V. Valerie. "Psychiatric Considerations in Management of Movement Disorders." In Textbook of Stereotactic and Functional Neurosurgery, 1487–96. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-69960-6_88.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Starkstein, Sergio E., and Jaime Pahissa. "Psychiatric Complications of Alzheimer’s Disease Overlapping with Parkinsonism: Depression, Apathy, Catatonia, and Psychosis." In Movement Disorders in Dementias, 73–86. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6365-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Meeks, Thomas W., and Dilip V. Jeste. "Medication-Induced Movement Disorders." In Psychiatry, 1773–93. Chichester, UK: John Wiley & Sons, Ltd, 2008. http://dx.doi.org/10.1002/9780470515167.ch84.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lam, Kevin, and Barbara J. Coffey. "Movement Disorders: Tics and Tourette's Disorder." In Clinical Child Psychiatry, 399–417. Chichester, UK: John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781119962229.ch23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Isaias, Ioannis U., and Michele Tagliati. "Deep Brain Stimulation Programming for Movement Disorders." In Deep Brain Stimulation in Neurological and Psychiatric Disorders, 361–97. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-360-8_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ren, Juanjuan, Chenyu Ye, and Chen Zhang. "Dance Movement Therapy as an Alternative for Rehabilitating People with Mental Disorders." In Arts Therapies in Psychiatric Rehabilitation, 113–15. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-76208-7_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Siddiqui, Mustafa Saad, Thomas Ellis, Stephen S. Tatter, Kelly D. Foote, and Michael S. Okun. "Deep Brain Stimulation: Patient Selection in Parkinson's Disease, Other Movement Disorders, and Neuropsychiatric Disorders." In Deep Brain Stimulation in Neurological and Psychiatric Disorders, 83–98. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-360-8_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pinsker, Marcus, Florian Amtage, Mathias Berger, Guido Nikkhah, and Ludger Tebartz Elst. "Psychiatric Side-Effects of Bilateral Deep Brain Stimulation for Movement Disorders." In Stereotactic and Functional Neurosurgery, 47–51. Vienna: Springer Vienna, 2013. http://dx.doi.org/10.1007/978-3-7091-1482-7_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bullock, Kim, and Juliana Lockman. "Psychiatric Comorbidities and the Role of Psychiatry in Functional Movement Disorder." In Current Clinical Neurology, 291–310. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-86495-8_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Movement and psychiatric disorders"

1

Figueiredo, Camila Angelo Vidal de, Kaline dos Santos Kishishita Castro, and Sílvia Raimunda Costa Leite. "Therapeutic management of movement disorders present in Huntington’s Disease: a literature review." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.430.

Full text
Abstract:
Background: Huntington’s Disease (HD) is a hereditary neurodegenerative genetic disease with motor, cognitive and behavioral repercussions that interferes in several areas of the patients’ lives. Therefore, to increase the quality of life for patients the therapeutic management of symptoms is necessary. Objective: to elucidate the main forms of treatment that reduces motor disorders present in HD. Methods: an integrative literature review was conducted using scientific articles published between 2016-2020 about this topic found in Pubmed and Google Scholar databases. Results: the chorea treatment in HD can be done using Tetrabenazine, deutetrabenazine or antipsychotics. During a study by the Huntington Study Group (HSG), tetrabenazine proved its efficacy, however, due to several adverse effects, its use was reduced. Thus, deutetrabenazine was created, which consists in a tetrabenazine deuterated version, with a longer half- life and less adverse effects. Studies by the HSG found that besides reducing chorea, it also improves motor function in general in patients. Antipsychotics are used when the patient has behavioral and psychiatric symptoms that prevent him from using the other drugs. The dystonia treatment involves physiotherapy and botulinum toxin injections, which are also used in the bruxism therapy, along with mouth protectors. Abnormal gait and balance problems can be reduced with psychomotor rehabilitation, physiotherapy, and using a walker. Conclusion: the control of HD motor symptoms is an important way to increase patients’ quality of life. Therefore, more studies are necessary to expand the effective therapeutic options.
APA, Harvard, Vancouver, ISO, and other styles
2

Sinmaz, N., F. Tea, D. Pilli, A. Zou, T. Nguyen, V. Merheb, S. Ramanathan, R. Dale, and F. Brilot. "266 Human autoantibodies from children with movement and psychiatric disorders target the extracellular n-terminus of dopamine-2 receptor." In LUPUS 2017 & ACA 2017, (12th International Congress on SLE &, 7th Asian Congress on Autoimmunity). Lupus Foundation of America, 2017. http://dx.doi.org/10.1136/lupus-2017-000215.266.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Monteiro, Ana Karoline da Costa, Paulo Filho Soares Marcelino, Marcello Holanda de Andrade, Rairis Barbosa Nascimento, Marx Lincoln Lima de Barros Araújo, and Samuel Pinheiro da Silva. "Fahr’s Syndrome: A Case Report." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.110.

Full text
Abstract:
Context: Fahr’s syndrome is a clinical entity of primary or secondary causes characterized by neurological and/or psychiatric symptoms associated with abnormal calcifications in basal ganglia, cerebellum and cerebral cortex. Case report: G.M.A, female, 49 years-old, presented athetosis in the distal extremity of the right upper limb (RUL) in December 2020, without seeking for medical help. Known to be diabetic, hypertensive and with diastolic heart failure (HF), in February 2021 she presented decompensated HF associated with worsening of involuntary movements in the RUL. During investigation, abnormalities in serum levels of parathormone (PTH) and calcium were observed, in addition to bilateral calcifications in basal ganglia and thalamus in brain computed tomography (CT) without contrast. In March 2021, she was admitted to the University Hospital of the Federal University of Piauí, with maintenance of athetosis at the distal extremity of the RUL, in addition to oromandibular dyskinesia. Laboratory profile compatible with primary hypoparathyroidism and new brain CT without contrast with calcifications in basal ganglia and pulvinar of the thalamus, bilaterally, were confirmed. Intravenous calcium replacement and use of calcitriol were performed, with partial clinical improvement. Conclusions: Fahr’s syndrome is characterized by the presence of movement disorders (with highlights for parkinsonism and athetosis) and psychiatric symptoms (depression most commonly). Possible etiologies are primary (genetic) and secondary (mainly idiopathic or secondary hypoparathyroidism). Classic finding of symmetrical calcifications in base nuclei is seen on brain CT. Treatment is symptomatic and control of the underlying disease.
APA, Harvard, Vancouver, ISO, and other styles
4

Leite, Izabel Feitosa da Mata, Adelina Mouta Moreira Neto, Guilherme de Aguiar Moraes, Lucas Cardoso Siqueira Albernaz, and Matheus de Campos Medeiros. "Neuro-Behçet’s Syndrome: case report." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.209.

Full text
Abstract:
Context: Behçet’s Disease (BD) is a multisystem chronic disorder characterized by perivasculitis within several tissues, including the Central Nervous System – Neuro-Behçet’s Disease, which accounts for 3 – 9 % of the BD patients. Neuro- Behçet’s Syndrome may present as brainstem or pyramidal syndromes, myelopathies, meningoencephalitis, intracranial hypertension and movement or psychiatric disorders. The objective of the present work is to report a case of Neuro-Behçet’s Disease, a rare and disabling disorder. Case report: 24-year-old male presenting focal neurological deficits – hemiparesis on the right side and motor aphasia, associated with unstoppable hiccups and visual blurring. His previous pathological history featured several self-limiting episodes of the same neurological presentation, as well as acute exacerbations of oral and genital ulcers. Erythema Nodosum and Folliculitis were his main skin lesions. The ophthalmological evaluation showed bilateral cicatricial chorioretinitis. Laboratorial diagnostic procedures revealed left shift leukocytosis, high ESR, high protein level in the CSF and negative serology for B and C hepatitis, HTLV, HIV and toxoplasmosis. P-ANCA, C-ANCA, ANA and Rheumatoid factor were all found negative. Magnetic Resonance Imaging of the brain showed multiple oval- shaped T2- hyperintensity foci, with adjacent vasogenic edema, in the brainstem and basal ganglia areas – suggesting vasculitis. Treatment involved pulse therapy with Methylprednisolone, followed by Azathioprine and Prednisone. The patient has had full recovery and no other relapses. Conclusions: This case illustrates the importance of investigating Neuro-Behçet’s Disease in patients with neurological symptoms and oral/genital ulcers. The goal is to establish adequate and early treatment to improve the quality of life.
APA, Harvard, Vancouver, ISO, and other styles
5

Vasconcellos, Barbara Cunha, Tamie Mota Arbex, Aline Silva Ziehe, Lara Cruz de Senna-Fernandes, Samantha Golçalves Barbosa, Tatiana Virgínia Fidélis Cordeiro, and Caio Andrade Prins Rodrigues. "Psychomotor consequences in children with Tourette’s Syndrome." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.385.

Full text
Abstract:
Background: Tourette’s Syndrome (TS) has a neuropsychiatric aspect and a chronic repertoire of motor-phonic tics. The common onset is in infants and remission in adults. Objective: investigate psychomotor consequences in children with TS. Design and settings: literature review. Methods: eleven studies were selected from a group of 20 after searching the MEDLINE database for “psychomotor performance OR psychomotor development” and “Tourette’s Syndrome”. Only articles with full texts available and published from 2011-2021 were included. Results: the response time (RT) of children with TS was longer. Throughout Do/Don’t tasks, with/without false alarms, the RT was lower while the accuracy of movement (AM) was greater. A study on RT and AM with different levels of complexity showed greater difficulty in ST group (p<0.001) with RT increasing according to complexity. Many children with TS also had ADHD, and when comparing them to the ones only with TS, the ADHD+TS group made more mistakes while having the same RT. The ADHD+TS group also had a response blockage in non-sequential tests and lower TS in sequential tests (p=0.006). Studies showed an association between motor tics and forgetfulness rate (FR), with these being inversely proportional. Conclusion: children with TS have greater RT and the response to uni and bimodal stimuli differ, with greater AM and lower RT to single stimulus. More severe tics were associated with better content retention. Other psychiatric disorders are common, especially ADHD, requiring further studies to link the consequences of each pathology accordingly.
APA, Harvard, Vancouver, ISO, and other styles
6

Braun, D., J. Schlossmann, and E. Haen. "Asymmetric dimethylarginine in psychiatric disorders." In XIIIth Symposium of the Task Force Therapeutic Drug Monitoring of the AGNP. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1649527.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Psycho-Behavioral and Socio-Economic Characteristics of Juvenile Delinquency in Wasit Province at 2016 To 2020." In 4th International Conference on Biological & Health Sciences (CIC-BIOHS’2022). Cihan University, 2022. http://dx.doi.org/10.24086/biohs2022/paper.766.

Full text
Abstract:
BACKGROUND: one of the serious behavioral problems that affect youth health mentally, physically and socially is Juvenile delinquency. The act by a juvenile is considered delinquency if it is considered a crime when committed by an adult, as well as illegal acts because of offenders age.OBJECTIVE: Is to determine the psycho-behavioral and socio-economic profile of juvenile offenders in Wasit Province. STUDY DESIGN: A cross-sectional hospital-based study targeted all delinquents (n=510) who referred by criminal courts to psychiatric unit for personality study using ICD-10 clinical based interview during 2016 to 2020. Data collected from files of offenders by a routine interviewing (with highly secured information). RESULTS: The mean age ±SD of the indicted was 17.9±2.9 years, male youths consist 96%, with a history of low socioeconomic status, 74% of them lived within family size of ≥7 members; 50% rank in 1st. to 3rd. in among all siblings in their families; 17% losses their fathers. Of total sample, one-half of offenders presented with school dropout and 44% engaged in premature labor. Most of youth presented with good mental health, sometimes they appear with consistent personality only 19 (4%) of them presented with speech and movement disorder, and unstable and uncooperative personality. Of 290 delinquents; 108 (37%) were tobacco smoker and 43 (15%) presented with tattoo. Dropout offenders presented with fourfold smoking and tattoo than students with an Odds Ratios of 3.8 (95% CI 2.25-6.4), and 4.0 (95% CI 1.9-8.7) respectively. 5% of youths have a history of previous offence. (38%) of offenders accused with theft or robbery crimes followed by homicide (16%) and physical fighting or scrimmage (12%). CONCLUSIONS: According to the psychiatric interview, the majority of the indicted were not mentally ill. Low socioeconomic status, live in large family, losses fathers, school dropout, and premature work all these factors may contribute to increase the burden of juvenile delinquency in Wasit province. The prevalence of healthy risk behavior in school dropout delinquents more than in students. Theft and robbery, homicide and physical fighting as a crimes were on the top of the list. Educational and health programs that encourage children to enrolled school and increase awareness of negative impact of juvenile delinquency on individual and community should be considered urgently.
APA, Harvard, Vancouver, ISO, and other styles
8

PRIEST, ROBERT G., and M. ROBERTS. "REVERSIBLE AND SELECTIVE MAOIs IN PSYCHIATRIC AND NON-PSYCHIATRIC DISORDERS." In IX World Congress of Psychiatry. WORLD SCIENTIFIC, 1994. http://dx.doi.org/10.1142/9789814440912_0209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chirita, Anca Livia, Mihaela Popescu, Veronica Calborean, Victor Gheorman, and Ion Udristoiu. "PSYCHIATRIC DISORDERS ASSOCIATED WITH ENDOCRINE DYSFUNCTIONS." In The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.25.

Full text
Abstract:
Introduction: Psychiatric disorders occurring during endocrine dysfunction and, conversely, endocrine dysfunctions associated with mental disorders were the emergence of a new discipline, psychoendocrinology. Psychiatric disorders correlated with endocrine diseases are defined as psychopathological manifestations of variable intensity and clinical symptomatology, determined by complex psycho-neuro-endocrinological interrelationships. Defining elements consist of the association between diagnosis of mental disorders and specific symptoms for endocrine dysfunction. Methods: We conducted a prospective one-year study (January 2018 - December 2018 on 112 patients hospitalized in the Clinic of Psychiatry who also had an endocrinological comorbidity. We investigated the frequency and severity of psychoendocrinological associations by studying a number of demographic and clinical items. Results: The results showed that the highest incidence belongs to thyroid disorder - 55.36%, followed by gonadal disorders - 24.11%, and, rarely, pituitary diseases and diabetes. Hyperthyroidism was associated most frequently with manic episodes, while unipolar depression prevailed in patients with hypothyroidism. In gonadal disorders, present in majority in female patients (secondary amenorrhea, menopause or erectile dysfunction in males), depression accompanied by anxiety, often severe in intensity, was the most frequent psychiatric diagnosis. Psychotic disorders were met in a smaller number of cases, especially in patients with long history of endocrine disorders and instability of biological constants. Conclusions: We may state that affective disorders are the most frequent nosologically category in patients with endocrine dysfunctions. It requires a better collaboration between specialists in endocrinology and psychiatry, to highlight the determinants which contribute to the development of psychopathological manifestations in endocrine diseases and to individualize the treatment depending on cases’ particularities.
APA, Harvard, Vancouver, ISO, and other styles
10

Rosu, Ioana, Alina Ioana Voinea, and Petronela Nechita. "FACTITIOUS DISORDERS – CHALLENGES IN PSYCHIATRIC DIAGNOSIS." In The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.23.

Full text
Abstract:
Introduction: Factitious disorders is a group of psychiatric pathologies in which a person acts as if he has an illness by deliberately producing or exaggerating symptoms on them, or sometimes they use a “victim” in order to catch the attention of the others. Usually, the real causes for this kind of behavior are emotional impairments and personality disorders. Munchausen syndrome and Munchausen by proxy syndrome are the most known of these disorders. Aim: The aim of this paper is to raise awareness for this kind of disorder because they are an extensive problem for the medical system and in many cases, they are hard to diagnose and manage. Method: We started by observing and documenting an unusual case of Munchausen syndrome at a patient from Infantile Neuropsychiatric Clinic of Psychiatry Institute “Socola”, Iasi and her mother with Munchausen by proxy syndrome. We compered this pair of cases with data reviews on the subject to see what are the challenges that are common for this kind of pathologies and how we can manage them. Conclusions: We concluded that factitious disorders are more common that is thought they are. Doctors tend to let this diagnose on the last place because the priority is to resolve the somatic symptoms of the patient. That is why we must acknowledge and understand how to manage this kind of mental disorder.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Movement and psychiatric disorders"

1

Ettner, Susan, Richard Frank, and Ronald Kessler. The Impact of Psychiatric Disorders on Labor Market Outcomes. Cambridge, MA: National Bureau of Economic Research, April 1997. http://dx.doi.org/10.3386/w5989.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dr. Jogeshwar Mukherjee. Development of dopamine receptor radiopharmaceuticals for the study of neurological and psychiatric disorders. Office of Scientific and Technical Information (OSTI), January 2009. http://dx.doi.org/10.2172/944919.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chatterji, Pinka, Margarita Alegria, and David Takeuchi. Psychiatric Disorders and Labor Market Outcomes: Evidence from the National Comorbidity Survey - Replication. Cambridge, MA: National Bureau of Economic Research, October 2008. http://dx.doi.org/10.3386/w14404.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chatterji, Pinka, Margarita Alegria, Mingshan Lu, and David Takeuchi. Psychiatric Disorders and Labor Market Outcomes: Evidence from the National Latino and Asian American Study. Cambridge, MA: National Bureau of Economic Research, December 2005. http://dx.doi.org/10.3386/w11893.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fortney, Johny, and Jürgen Unützer. Comparing Two Telehealth Approaches for Treating Complex Psychiatric Disorders in Primary Care -- The SPIRIT Study. Patient-Centered Outcomes Research Institute® (PCORI), August 2022. http://dx.doi.org/10.25302/08.2022.pcs.140619295.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mukherjee, J. Development of dopamine receptor radiopharmaceuticals for the study of neurological and psychiatric disorders. Progress report 1994--1997. Office of Scientific and Technical Information (OSTI), August 1999. http://dx.doi.org/10.2172/764610.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Yanliang, Mei, Liu Xiaojing, Yuan Yanpeng, Li Lanjun, Xu Yuming, and Yang Jing. Transcranial sonography of substantia nigra for differential diagnosis of Parkinson's disease and other movement disorders: A Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2020. http://dx.doi.org/10.37766/inplasy2020.6.0068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Timm, Eliane, Julia Vieregg, and Ursula Wolf. Movement based mindfulness therapies in patients with multiple sclerosis – a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0102.

Full text
Abstract:
Review question / Objective: The aim is to review the clinical benefits of mindful moving techniques for persons with multiple sclerosis. Condition being studied: Multiple sclerosis. Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (Gholamzad et al., 2019; Oh, Vidal-Jordana, & Montalban, 2018). It has shown to be increasing since 2013, and as of 2020 the estimated number of people with MS is 2.8 million worldwide (Walton et al., 2020). Due accumulation of relapses or gradual progression, disability from MS is worsening over time (Cameron & Nilsagard, 2018), which results in common symptoms like pain, imbalance, weakness, motor disorders, fatigue, depression, and more (Cameron & Nilsagard, 2018; Guicciardi et al., 2019).
APA, Harvard, Vancouver, ISO, and other styles
9

Madu, Laura, Jacqueline Sharp, and Bobby Bellflower. Efficacy of Integrating CBT for Mental Health Care into Substance Abuse Treatment in Patients with Comorbid Disorders of Substance Abuse and Mental Illness. University of Tennessee Health Science Center, April 2021. http://dx.doi.org/10.21007/con.dnp.2021.0004.

Full text
Abstract:
Abstract: Multiple studies have found that psychiatric disorders, like mood disorders and substance use disorders, are highly comorbid among adults with either disorder. Integrated treatment refers to the treatment of two or more conditions and the use of multiple therapies such as the combination of psychotherapy and pharmacotherapy. Integrated therapy for comorbidity per numerous studies has consistently been superior to the treatment of individual disorders separately. The purpose of this QI project was to identify the effectiveness of Cognitive Behavioral Therapy (CBT) instead of current treatment as usual for treating Substance Use Disorder (SUD) or mental health diagnosis independently. It is a retrospective chart review. The review examines CBT's efficacy for engaging individuals with co-occurring mood and substance u se disorders in treatment by enhancing adherence and preventing disengagement and relapse. Methods: Forty adults aged 26-55 with a DSM-IV diagnosis of a mood disorder of Major Depressive Disorder and/or anxiety and concurrent substance use disorder (at least weekly use in the past month). Participants received 12 sessions of individual integrated CBT treatment delivered with case management over a 12-week period. Results: The intervention was associated with significant improvements in mood disorder, substance use, and coping skills at 4, 8, and 12 weeks post-treatment. Conclusions: These results provide some evidence for the effectiveness of the integrated CBT intervention in individuals with co-occurring disorders. Of note, all psychotherapies are efficacious; however, it would be more advantageous to develop a standardized CBT that identifies variables that facilitate treatment outcomes specifically to comorbid disorders of substance use and mood disorders. It is concluded that there is potentially more to be gained from further studies using randomized controlled designs to determine its efficacy.
APA, Harvard, Vancouver, ISO, and other styles
10

Zhu, Qiqi, Jie Deng, Chong Xu, Meixi Yao, and Yu Zhu. Effects of physical activity on visuospatial working memory in healthy individuals: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0053.

Full text
Abstract:
Review question / Objective: P: Healthy individuals (including children, adolescents, adults, and seniors); I: Individuals who join various physical activities (including aerobic exercise, HIT, yoga, resistance training, Tai Chi, balance training, skill training, et al); C: Individuals who have no movement, do reading, or do same as normal activities; O: 1-Back Test, 2-Back Test, Trail Making Test-A, Trail Making Test-B, Digit Span Forward, Digit Span Backward; S: Randomized Controlled Trial (RCT). Condition being studied: Healthy individuals without any cognitive disorders.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Movement and psychiatric disorders' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography